EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
E Sánchez-Tilló, Y Liu, O de Barrios, L Siles… - Cellular and molecular …, 2012 - Springer
Cancer is a complex multistep process involving genetic and epigenetic changes that
eventually result in the activation of oncogenic pathways and/or inactivation of tumor …
eventually result in the activation of oncogenic pathways and/or inactivation of tumor …
Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma
CS Scanlon, EA Van Tubergen… - Journal of dental …, 2013 - journals.sagepub.com
An understanding of the process by which tumor cells destroy the basement membrane of
the surface epithelium, invade, and metastasize is essential to the development of novel …
the surface epithelium, invade, and metastasize is essential to the development of novel …
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Neoplastic cells within individual carcinomas often exhibit considerable phenotypic
heterogeneity in their epithelial versus mesenchymal-like cell states. Because carcinoma …
heterogeneity in their epithelial versus mesenchymal-like cell states. Because carcinoma …
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
Objective Distant metastasis is the major cause of cancer-related death in patients with
colorectal cancer (CRC). Although the microRNA-200 (miR-200) family is a crucial inhibitor …
colorectal cancer (CRC). Although the microRNA-200 (miR-200) family is a crucial inhibitor …
Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma
M Natsuizaka, KA Whelan, S Kagawa, K Tanaka… - Nature …, 2017 - nature.com
Notch1 transactivates Notch3 to drive terminal differentiation in stratified squamous
epithelia. Notch1 and other Notch receptor paralogs cooperate to act as a tumor suppressor …
epithelia. Notch1 and other Notch receptor paralogs cooperate to act as a tumor suppressor …
Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement
P Rousselle, JY Scoazec - Seminars in cancer biology, 2020 - Elsevier
Laminin 332 is crucial in the biology of epithelia. This large extracellular matrix protein
consists of the heterotrimeric assembly of three subunits–α3, β3, and γ2–and its …
consists of the heterotrimeric assembly of three subunits–α3, β3, and γ2–and its …
DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis
Emerging evidence demonstrates that the DNA repair kinase DNA-PKcs exerts divergent
roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo …
roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo …
The opposing roles of laminin-binding integrins in cancer
V Ramovs, L Te Molder, A Sonnenberg - Matrix Biology, 2017 - Elsevier
Integrins play an important role in cell adhesion by linking the cytoskeleton of cells to
components in the extracellular matrix. In this capacity, integrins cooperate with different cell …
components in the extracellular matrix. In this capacity, integrins cooperate with different cell …
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
JT Nauseef, MD Henry - Nature reviews Urology, 2011 - nature.com
The lethal consequences of prostate cancer are related to its metastasis to other organ sites.
Epithelial-to-mesenchymal transition (EMT) has received considerable attention as a …
Epithelial-to-mesenchymal transition (EMT) has received considerable attention as a …
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
P Li, R Yang, WQ Gao - Molecular cancer, 2014 - Springer
An important clinical challenge in prostate cancer therapy is the inevitable transition from
androgen-sensitive to castration-resistant and metastatic prostate cancer. Albeit the …
androgen-sensitive to castration-resistant and metastatic prostate cancer. Albeit the …